| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.04B | 48.13B | 40.64B | 34.81B | 27.95B | 24.44B |
| Gross Profit | 9.43B | 9.03B | 7.78B | 7.01B | 5.81B | 5.06B |
| EBITDA | 4.28B | 3.91B | 3.07B | 2.57B | 2.02B | 1.51B |
| Net Income | 2.01B | 1.81B | 1.51B | 1.27B | 1.12B | 666.53M |
Balance Sheet | ||||||
| Total Assets | 30.73B | 31.60B | 25.54B | 21.23B | 18.14B | 15.92B |
| Cash, Cash Equivalents and Short-Term Investments | 4.60B | 4.68B | 4.06B | 3.49B | 3.51B | 3.11B |
| Total Debt | 8.82B | 9.47B | 5.93B | 3.98B | 2.75B | 2.11B |
| Total Liabilities | 17.14B | 18.09B | 13.22B | 10.36B | 8.28B | 7.00B |
| Stockholders Equity | 13.58B | 13.51B | 12.31B | 10.87B | 9.86B | 8.91B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.20B | 163.47M | 328.25M | 874.93M | 267.11M |
| Operating Cash Flow | 0.00 | 2.37B | 3.03B | 665.05M | 1.48B | 508.96M |
| Investing Cash Flow | 0.00 | -4.53B | -3.27B | -1.34B | -1.00B | -534.41M |
| Financing Cash Flow | 0.00 | 2.75B | 818.57M | 714.62M | -107.72M | -101.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥14.18B | 8.60 | ― | 3.04% | 4.45% | 29.58% | |
77 Outperform | ¥15.84B | 11.63 | ― | 3.37% | 3.18% | -23.51% | |
75 Outperform | ¥25.08B | 7.29 | ― | 2.33% | 22.91% | 61.68% | |
74 Outperform | ¥156.58B | 9.98 | ― | 3.65% | 7.73% | -19.90% | |
73 Outperform | ¥79.78B | 6.51 | ― | 3.48% | 4.17% | 24.54% | |
73 Outperform | ¥15.43B | 7.26 | ― | 3.85% | 4.96% | 38.47% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |